Skip to main content
Journal of Patient-Reported Outcomes
Fig. 5 | Journal of Patient-Reported Outcomes

Fig. 5

From: A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice

Fig. 5

Scatterplot of PRO compliance percentage at the primary PRO analysis timepoint and CONSORT-PRO reporting score. Legend: PRO compliance rate was clearly reported for 10 of the 36 RCTs included in this study. The mean PRO CONSORT-PRO score for these 10 RCTs was 10.5/14, range: 4–13/14. Compliance data was not reported adequately in the remaining 26 RCT publications, therefore these have been excluded here. The mean CONSORT-PRO score for these 26 RCTs was 5.3/14, range 0–13.5/14

Back to article page